Do you want to remove all your recent searches?

All recent searches will be deleted

Watch fullscreen

India lose $4.68 trillion between 2012 and 2030 due to non-communicable diseases.

Mint
Mint
last year|1 view
However, this is an opportunity for companies to invest in preventive health and a robust pharmaceutical sector to address this market. Norbert Hültenschmidt, director and head, healthcare practice – Europe, Middle East and Asia (EMEA) at Bain & Co, spoke about opportunities for Indian pharmaceutical companies in domestic and international markets, why pipeline for patented drugs is drying up globally and which areas Indian pharmaceutical companies are targeting for drug development.